-

Shareholder Alert: Robbins LLP is Investigating Apache Corporation (APA) on Behalf of Shareholders

SAN DIEGO & HOUSTON--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Apache Corporation (NASDAQ: APA) on behalf of shareholders to determine whether certain Apache officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Apache is an independent energy company that explores for, develops and produces natural gas, crude oil and natural gas liquids. One of Apache's purported key "core growth areas" is the Permian region in West Texas and New Mexico.

If you suffered a loss due to Apache Corporation's misconduct, click here.

Apache Corporation (APA) Misled Shareholders About the Viability of its Alpine High Resource Play

On September 7, 2016, Apache announced the discovery of a new resource play in the Permian Basin called Alpine High that was rich in oil and gas reserves. Apache touted the discovery as providing a "large inventory of repeatable, high-value drilling opportunities" and reinforced these sentiments throughout 2016, 2017 and 2018. Notably, the Company's quarterly financial results for 2018 were positive, with Apache CEO John J. Christmann IV stating that "2018 will be a year in which Apache differentiates itself operationally, particularly in the Permian Basin." On August 1, 2018, Christmann highlighted "another great quarter" as it exceeded guidance and raised the 2018 outlook. However, these statements were materially false and misleading and failed to disclose material adverse facts about Apache's business operations. Specifically, Apache failed to disclose that it used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High, and that it did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported. These statements artificially inflated the value of the Company's operations in the Permian Basin.

The lack of Alpine High's viability emerged through a series of disclosures between April 2019 and March 2020, which resulted in a significant decline in the price of Apache's stock. By March 13, 2020, Apache's stock was trading at just $4.46.

Apache Corporation (APA) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Apache Corporation settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...
Back to Newsroom